Christopher B. Prentiss
Finanzdirektor/CFO bei MANNKIND CORPORATION
Aktive Positionen von Christopher B. Prentiss
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MANNKIND CORPORATION | Comptroller/Controller/Auditor | 22.04.2024 | - |
Finanzdirektor/CFO | 22.04.2024 | - |
Karriereverlauf von Christopher B. Prentiss
Ehemalige bekannte Positionen von Christopher B. Prentiss
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ADAMAS PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01.09.2017 | 01.11.2019 |
Finanzdirektor/CFO | 01.11.2019 | 24.11.2021 | |
INTERMUNE INC | Comptroller/Controller/Auditor | 01.06.2013 | 01.03.2015 |
DYNAVAX TECHNOLOGIES CORPORATION | Comptroller/Controller/Auditor | 01.05.2012 | 01.06.2013 |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.10.1997 | 01.07.2005 |
MANNKIND CORPORATION | Comptroller/Controller/Auditor | - | - |
Ausbildung von Christopher B. Prentiss
Loyola Marymount University | Undergraduate Degree |
Indiana University | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Comptroller/Controller/Auditor | 5 |
Director of Finance/CFO | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
MANNKIND CORPORATION | Health Technology |
Private Unternehmen | 3 |
---|---|
Adamas Pharmaceuticals LLC
Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
- Börse
- Insiders
- Christopher B. Prentiss
- Erfahrung